Lobbying Information
Subject Matters
- Health
- Industry
- Intellectual Property
- Internal Trade
- International Trade
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Industry Canada regarding export provisions of the Patent Act.
- Industry Canada with respect to the Patent Act as it pertains to pharmaceuticals.
- Modernization of the Food and Drug Act (formerly Bill C-51) with respect to the development and implementation of a Progressive Licensing Framework for pharmaceuticals.
Policies or Program
- Health Canada regarding the need for appropriate, dedicated resources for the Therapeutic Products Directorate to meet performance targets for the review of generic drug submissions.
- Health Canada, Industry Canada, and International Trade Canada regarding effective measures to combat counterfeit drugs in Canada and around the world.
- Science and Technology Strategy regarding the need for a balanced Intellectual Property (IP) regime and the important role competition plays in encouraging innovation.
- The development and implementation of an approval pathway for Subsequent Entry Biologics (SEBs).
Regulation
- Amendments to the Patented Medicines (Notice of Compliance) Regulations with regard to section 8 of the regulations, the inclusion of a mechanism that would prevent a brand company from suing a generic company twice on the same patent and an administrative change to explicitly allow a generic company to amend a Notice of Allegation.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Health Canada (HC)
-
House of Commons
-
Industry Canada
-
Prime Minister's Office (PMO)
-
Senate of Canada
In-house Corporation Details
Description of activities
Cobalt is a fully integrated organization, focused primarily on generic pharmaceutical products.
Responsible officer name and position during the period of this registration
Jean-Guy Goulet,
President
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
6500 Kitimat Road
Mississauga, ON L5N 2B8
Canada
Telephone number:
905-813-5444
Fax number:
905-813-5509
Parent Company Information
- Watson Pharmaceuticals
-
Morris Corporate Centre III, 400 Interpace Pkwy
Parsippany, NJ 07054
United States of America
Subsidiary Beneficiary Information
Cobalt Pharmaceuticals Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Jean-Guy Goulet,
President |
No public offices held
- Henry Koziarski,
Chief Financial Officer |
No public offices held
- Connie Lin,
Director Regulatory Affairs |
No public offices held
- Kent Major,
Vice-President, Scientific Affairs |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Jane Farnham-Verway,
Vice President, Corporate Affairs |
No public offices held
